Skip to main content
Clinical Trials/NCT04505020
NCT04505020
Enrolling by Invitation
N/A

The Innovation of 3D Printing for Preoperative Planning in Hip Preservation Surgery

Nova Scotia Health Authority1 site in 1 country80 target enrollmentJanuary 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Femoro Acetabular Impingement
Sponsor
Nova Scotia Health Authority
Enrollment
80
Locations
1
Primary Endpoint
Measure of CAM resection
Status
Enrolling by Invitation
Last Updated
last year

Overview

Brief Summary

This is a randomized controlled trial (RCT) to evaluate the introduction of a 3D printed model into the pre and intra-operative planning for arthroscopic femoroacetabular impingement (FAI) surgery. The RCT will look to place patients into one of two treatment groups: 1) conventional preoperative imaging (X-ray, CT, and MRI) only and 2) those that have had a 3D printed model created in addition to the conventional imaging.

Detailed Description

In this study, we investigate the use of 3D models during pre and intra-operative planning could improve the success of hip arthroscopy and reduce the incidence of revision cases. By adding an adjunct to the common suite of pre-operative imaging modalities (X-ray, MRI and CT), we can change the surgeon's understanding of each patient's individual morphology with a tactile physical model. This study will compare the success of hip arthroscopy in patients with or without 3D printed models (in addition to traditional pre-operative imaging). This will be a single-center, blinded observer, randomized controlled trial of 80 patients performed at the Halifax Infirmary, Queen Elizabeth II Health Sciences Center in Halifax, Nova Scotia. Patients with cam-type FAI involved in the study will be approached by the surgeon, Dr. Ivan Wong, or a delegate regarding the study during a pre-operative visit. Following a detailed discussion of the risks/benefits/alternatives of this study, the patient will be provided with a copy of the informed consent to review, if they demonstrate an interest in the study. If the patient wishes to be enrolled in the study, the research team will obtain patient consent for the study according to the Division of Orthopaedic Surgery and Nova Scotia Health Authority (NSHA) institutional protocols. In the pre-operative period, there will be no additional time requirements for the participant, except for the informed consent process for the study. Routine X-ray radiographs, as well as a pre-operative MRI and CT scan, will be obtained for all subjects undergoing FAI surgery. The participants will not be exposed to any additional radiation. Subjects will complete a structured clinical examination conducted by a sports medicine fellowship-trained orthopaedic consultant. The patient will also complete pre-operative questionnaires. Patients that have consented to the study will be randomized into two groups with a 50% chance of being in either group. Randomization will be done with a computer random number generator. Both groups will undergo routine pre-operative imaging but one group will also have a 3D print made from the 3D CT reconstruction. All patient groups will undergo hip arthroscopy for the treatment of their FAI.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
June 30, 2027
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ivan Wong, MD

Principal Investigator

Nova Scotia Health Authority

Eligibility Criteria

Inclusion Criteria

  • Radiological proven diagnosis of cam-type femoroacetabular impingement (FAI)

Exclusion Criteria

  • Patients with advanced arthritis (Tonnis Grade III or Kellgren-Lawrence Grade III or IV or evidence of less than 2 mm of joint space, as determined by conventional radiographs.)
  • Patients with 1cm2 (or greater) of cartilage delamination in the hip
  • Patients with type III or IV heterotopic ossification
  • Patients with avascular necrosis
  • Patients who are unable to provide informed consent
  • Patients who are undergoing revision hip arthroscopy
  • Patients who are pregnant
  • Patients who have the presence of local or systemic infection
  • Patients with an inability to cooperate with and/or comprehend post-operative instructions
  • Patients with nonvascular surgical sites (MRI proven)

Outcomes

Primary Outcomes

Measure of CAM resection

Time Frame: Change in Pre-op measurements compared to 24 months post-operatively

Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views.

Secondary Outcomes

  • Differences in post-operative patient reported outcomes: NAHS(Change in outcomes 24 months post operatively compared to Pre-operatively)
  • Differences in post-operative patient reported outcomes: EQ5D-VAS(Change in outcomes 24 months post operatively compared to Pre-operatively)
  • Differences in post-operative patient reported outcomes: iHOT-33(Change in outcomes 24 months post operatively compared to Pre-operatively)
  • Differences in post-operative patient reported outcomes: VR-12(Change in outcomes 24 months post operatively compared to Pre-operatively)
  • Differences in post-operative patient reported outcomes: EQ5D(Change in outcomes 24 months post operatively compared to Pre-operatively)
  • Differences in post-operative patient reported outcomes: HOS-Usual Activities(Change in outcomes 24 months post operatively compared to Pre-operatively)
  • Differences in post-operative patient reported outcomes: HOS-Sport(Change in outcomes 24 months post operatively compared to Pre-operatively)

Study Sites (1)

Loading locations...

Similar Trials